COVID-19 Impact on Global Biosimilars/Follow-on-Biologics, Market Insights and Forecast to 2026

COVID-19 Impact on Global Biosimilars/Follow-on-Biologics, Market Insights and Forecast to 2026

  • QYResearch
  • June 2020
  • Pharmaceutical
  • 119 pages

Report Description

1
1
Biosimilars/Follow-on-Biologics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars/Follow-on-Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Biosimilars/Follow-on-Biologics market is segmented into
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others

Segment by Application, the Biosimilars/Follow-on-Biologics market is segmented into
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others

Regional and Country-level Analysis
The Biosimilars/Follow-on-Biologics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biosimilars/Follow-on-Biologics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilars/Follow-on-Biologics Market Share Analysis
Biosimilars/Follow-on-Biologics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilars/Follow-on-Biologics business, the date to enter into the Biosimilars/Follow-on-Biologics market, Biosimilars/Follow-on-Biologics product introduction, recent developments, etc.
The major vendors covered:
Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)

Have query on this report?

Make an Enquiry
1 Study Coverage
1.1 Biosimilars/Follow-on-Biologics Product Introduction
1.2 Market Segments
1.3 Key Biosimilars/Follow-on-Biologics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
List of Tables
Table 1. Biosimilars/Follow-on-Biologics Market Segments
Table 2. Ranking of Global Top Biosimilars/Follow-on-Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Human growth hormone
Table 5. Major Manufacturers of Erythropoietin

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074